Explore how Bristol Myers Squibb uses AI to validate drugs before they’re even in the lab in this Trendline.
While drug discovery was an early target for AI capabilities, the technology’s predictive powers have made it a good fit for many other facets of the industry. As pharma leverages real-world uses of AI, the industry has also been careful about big-picture hype for the technology as some of its limitations become clear.
included in this trendline
- AI’s ‘massive transition’ in biopharma shapes leadership mindsets — tension and all
- FDA’s Elsa AI is here, and the industry has questions
- How Bristol Myers Squibb uses AI to validate drugs before they’re even in the lab
Offered Free by: PharmaVoice and PPD
See All Resources from: PharmaVoice and PPD
